HALO logo
halo search icon
AstraZeneca PLC
AstraZeneca PLC
AZN · NYS

AstraZeneca PLC

US$187.46

Price Arrow2.82 (1.53%)
20/05/2026 04:10:00 PM
All-CompaniesAll-ConsensusEMA 125 BreakdownHALO AllHALO Capital EfficiencyHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AstraZeneca PLC Overview

AZN Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

HALO Model

Mqv

Strong

Garp

Strong

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Neutral

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About AZN

icon

Website

AstraZeneca PLC

icon

Telephone

icon

Address

Description

AstraZeneca Plc is a global, science-led biopharmaceutical company focused on the discovery, development, and commercialization of prescription medicines. Its portfolio spans oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal & metabolism, and respiratory & immunology. The company was founded in 1913 and is headquartered in Cambridge, the United Kingdom.

AZN Price Chart

Key Stats

Market Cap

US$287.25B

PE

28.10

EV/EBITDA

16.1

Dividends Overview

DIV Yield

1.7%

Franking

N/A

Ex Dividend Date (est.)

20-Feb-26

Market Data

52 weeks range

Low 134.9 - 212.71

Trade Value (12mth)

US$30,543,792.00

1 week

1.69%

1 month

-5.69%

YTD

1.08%

1 year

33.56%

All time high

212.71

Key Fundamentals

EPS 3 yr Growth

210.60%

EBITDA Margin

33.20%

Operating Cashflow

$14,861m

Free Cash Flow Return

20.80%

ROIC

14.30%

Interest Coverage

14.60

Quick Ratio

0.70

Other Data

Shares Outstanding (Fully Diluted)

1,561m

HALO Sector

Healthcare

Next Company Report Date

11-Feb-27

Next Ex Dividend Date

20-Feb-26

Next Dividend Pay Date

23-Mar-26

Reporting Currency

USD

Short Sell (% of issue)

0.00

AZN Announcements

Latest Announcements

DateAnnouncements
19 May 26
18 May 26
18 May 26
14 May 26
02 May 26

AZN Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock3.844.546.6locklocklock
EPS (Fully Diluted)
$locklocklocklock3.814.56.55locklocklock
Growth
%locklocklocklock8118.145.3locklocklock
PE
Xlocklocklocklock35.128.928.1locklocklock
EV/EBITDA
Xlocklocklocklock16.312.916.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

20-Feb-26

DIV Yield

1.7%

Franking Level

N/A

DPSg

-0.8%

Quality Yield

lock

Falling Divs over next 2

lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Want to learn more?Frequently asked questions.
What is the current share price of AstraZeneca PLC (AZN:NYS)?
Halo FAQ
The current share price of AstraZeneca PLC (AZN:NYS) is USD$187.46.
What is the 52-week high share price for AstraZeneca PLC (AZN:NYS)?
Halo FAQ
The 52-week high share price for AstraZeneca PLC (AZN:NYS) is USD$212.71.
What is the 52-week low share price for AstraZeneca PLC (AZN:NYS)?
Halo FAQ
The 52-week low share price for AstraZeneca PLC (AZN:NYS) is USD$134.90.
What is the dividend yield for AstraZeneca PLC (AZN:NYS)?
Halo FAQ
The current TTM dividend payout for AstraZeneca PLC (AZN:NYS) is 1.70.
What was AstraZeneca PLC (AZN:NYS) last dividend payment?
Halo FAQ
The last dividend payment of AstraZeneca PLC (AZN:NYS) is USD$2.17.
What is the franking level for AstraZeneca PLC (AZN:NYS)?
Halo FAQ
AstraZeneca PLC (AZN:NYS) has a franking level of 0.00%.
In which sector is AstraZeneca PLC (AZN:NYS) classified?
Halo FAQ
AstraZeneca PLC (AZN:NYS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for AstraZeneca PLC (AZN:NYS)?
Halo FAQ
The current P/E ratio for AstraZeneca PLC (AZN:NYS) is 28.10.

See beyond the curve.

One solution for research, investing and portfolio management.